Metastatic basaloid-squamous cell carcinoma of the esophagus treated by 5-fluorouracil and cisplatin

Yoshihiro Shibata, Eishi Baba, Hiroshi Ariyama, Ryusuke Miki, Nobumichi Ogami, Shuji Arita, Baoli Qin, Hitoshi Kusaba, Kenji Mitsugi, Hirokazu Noshiro, Takashi Yao, Shuji Nakano

Research output: Contribution to journalArticlepeer-review

17 Citations (Scopus)

Abstract

Basaloid squamous cell carcinoma (BSC) of the esophagus is a rare malignant disease. We report here a patient with recurrent esophageal BSC, who was successfully treated by systemic chemotherapy containing 5-fluorouracil (5-FU) and cisplatin (CDDP). A 57-year-old woman was diagnosed as having squamous cell carcinoma of the esophagus upon endoscopic examination. Curative esophagectomy with lymph node dissection was performed under the thoracoscope. The pathological diagnosis of the surgical specimen was BSC. Five months after operation, the patient was diagnosed as having a recurrence of the BSC with metastases to the liver and spleen, and a right paraclavicular lymph node. She was given systemic chemotherapy consisting of continuous infusion of 800 mg/d of 5-FU and 3 h infusion of 20 mg/d of CDDP for 5 consecutive days every 4 wk. The metastatic lesions in the spleen and right paraclavicular lymph node disappeared, and the liver metastasis was apparently reduced in size after 2 courses of chemotherapy. The tumor regression was seen over 6 courses, with progression afterwards. Although subsequent treatment with CPT-11 and CDDP was not effective, docetaxel and vinorelbine temporarily controlled the tumor growth for 2 mo. 5-FU and CDDP combination may be useful for the patients with advanced BSC.

Original languageEnglish
Pages (from-to)3634-3637
Number of pages4
JournalWorld Journal of Gastroenterology
Volume13
Issue number26
DOIs
Publication statusPublished - Jul 14 2007

All Science Journal Classification (ASJC) codes

  • Gastroenterology

Fingerprint Dive into the research topics of 'Metastatic basaloid-squamous cell carcinoma of the esophagus treated by 5-fluorouracil and cisplatin'. Together they form a unique fingerprint.

Cite this